[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"second-degree-atrioventricular-block-mbitz-type-ii\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:second-degree-atrioventricular-block-mbitz-type-ii":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100552571","left-septal-or-deep-septal-pacing-to-prevent-pacing-induced-cardiomyopathy-100552571",false,"NCT06474819","Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy","DEEP","Inclusion Criteria:\n\n* First implant of a single-chamber or dual chamber pacemaker due to persistent bradycardia associated with high degree atrio-ventricular (AV) block (complete AV block or second degree type II AV block), with second-degree type I AV block (symptomatic or associated with intra-hisian or infra-hisian block), or with atrial fibrillation with symptomatic slow ventricular rate (\\\u003C45lpm).\n* LVEF\\>50% at echocardiography performed maximum 7 days before pacemaker implant.\n* Informed consent signature.\n\nExclusion Criteria:\n\n* Life expectancy \\\u003C12 months\n* Severe cardiac valvular abnormality requiring intervention\n* Unstable Angina, Acute myocardial infarction, coronary revascularization, valvular surgery or valvular percutaneous intervention in the 90 days prior to pacemaker implant.\n* Inclusion in another trial which may influence the results of this study.","ALL","18 Years",{"count":19,"type":20},326,"ESTIMATED","INTERVENTIONAL",[23],"NA","Multicenter randomized controlled trial which will include patients with left ventricular ejection fraction \\>50% requiring a first implant of a cardiac pacemaker with expected high pacing percentages.\n\nPatients will be randomized 1:1 to right ventricular apical pacing vs left septal or deep septal pacing. The primary endpoint will be pacing-induced cardiomyopathy during the first year of follow-up.",[26,27],"Complete Heart Block","Second Degree Atrioventricular Block Möbitz Type II","RECRUITING","2024-07-12",{"date":31,"type":32},"2024-07-15","ACTUAL",{"date":29,"type":32},{"date":35,"type":20},"2027-01-12",{"name":37,"class":38},"Institut d'Investigació Biomèdica de Bellvitge","OTHER",6]